IP Library Granted Patent US 7,411,041
Granted Patent B2
US 7,411,041 · App. 10/667,290 · Granted Aug 12, 2008

DCRS5 polypeptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,411,041
App. No.
10/667,290
Granted
Aug 12, 2008
Kind
B2
Abstract

Nucleic acids encoding mammalian, e.g., primate, receptors, purified receptor proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are described.

Claims (10)

1. A substantially pure or recombinant polypeptide comprising a sequence having at least 95% sequence identity with SEQ ID NO:2, wherein the polypeptide, when combined along with IL-12Rβ1, is able to form a functional receptor complex for p40/IL-B30.

2. A substantially pure or recombinant polypeptide comprising a sequence having at least 98% sequence identity with SEQ ID NO:2, wherein the polypeptide, when combined along with IL-12Rβ1, is able to form a functional receptor complex for p40/IL-B30.

3. A heterodimeric composition comprising the polypeptide of claim 1 and human IL-12Rβ1.

4. A kit comprising the polypeptide of claim 1 and instructions for use.

5. The kit of claim 4 , wherein the kit also contains:

a) human IL-12Rβ1 polypeptide;

b) human p40;

c) human IL-B30; or

d) human IL-B30/p40 polypeptides.

6. The polypeptide of claim 1 comprising a sequence having fewer than 5 substitutions relative to the sequence of SEQ ID NO:2.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →